Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Terminated 1 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Febrile Neutropenia 2 Urinary Bladder Neoplasms 1 Sepsis 1 Neoplasms 1 Fever 1 Emergencies 1

Interventions

Exercise 18 Drug Therapy 17 pembrolizumab 12 Capecitabine 11 Blood Specimen Collection 11 Surveys and Questionnaires 10 Radiotherapy 10 Dexamethasone 9 Paclitaxel 8 Standard of Care 7 Oxaliplatin 7 Nivolumab 7 Fluorouracil 7 Erlotinib Hydrochloride 7 apatinib 6 Interviews as Topic 6 Gemcitabine 6 Cisplatin 6 Therapeutics 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Injections 5 Everolimus 5 Docetaxel 5 Cyclophosphamide 5 Control Groups 5 Bevacizumab 5 sintilimab 4 atezolizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × Meropenem × Clear all

NCT05393505 2022-12-06

FRANCiS-NF

The University of Hong Kong

Phase 4 Unknown

Classical hematology

Emergencies, Neoplasms, Sepsis, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡